www.alpha-fusion.com
The startup develops alpha nuclear medicine therapy using astatine compounds to target and treat cancer cells with precision. By focusing on low-molecular-weight and antibody-introduced formulations, the company aims to enhance treatment efficacy and minimize side effects for patients undergoing cancer therapy.
Traction –/10
HQ unknown
- Biotechnology
Updated 3 days ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops alpha nuclear medicine therapy using astatine compounds to target and treat cancer cells with precision. By focusing on low-molecular-weight and antibody-introduced formulations, the company aims to enhance treatment efficacy and minimize side effects for patients undergoing cancer therapy.